Skip to main content
Signal8

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) Form 8-K — Jun 16, 2026

$LIXTForm 8-KItems 1.01, 3.02, 7.01, 9.01Filed Jun 16, 2026, 4:00 PM ET0001493152-26-028878Original filing

Lixte Biotechnology Holdings, Inc. entered into a definitive agreement to acquire Nomad Transportable Power Systems, Inc. via a reverse merger. Under the terms, Nomad stockholders will receive up to 50,500 shares of Series D Convertible Preferred Stock and 3,000,000 shares of common stock, which collectively represent a significant potential dilution given Lixte's approximately 15.3 million currently outstanding shares.

Key figures

Shares Outstanding
15292339
Common Shares Issued
3000000
Preferred Shares Issued
50500
Closing Cash Requirement
16500000
Nomad Revenue Growth2025
175%
Nomad Shares Outstanding
29741876
Nomad Projected Growth2026
135%
Preferred Conversion Shares
50500000

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) Form 8-K — Jun 16, 2026: AI Analysis | Signal8